RETeval: A Powerful Aid to Diagnose and Track DR
A Superior Assessment for Diabetic Retinopathy Progression Risk
Introducing the first objective tool to measure diabetic retinopathy progression risk like no other. The rapid and non-invasive RETeval ® device combines retina cell stress with pupil light response. This powerful combination provides a superior progression risk assessment. Measure all your diabetic retinopathy patients with the DR Assessment every visit to determine their risk of progression. Superior predictive power compared to the current Standard of Care (ETDRS stereo photography). Test in 2.3 minutes.[14] Approved CPT code 92273 in the US.
Superior DR Progression Risk Assessment
Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure. Translational Vision Science & Technology. August 2020, Vol.9, 40. doi:https://doi.org/10.1167/tvst.9.9.40
Comparative Ocular Intervention Rates Based on Testing Method[14]
Testing method | Incidence rate Yr. 1 | Incidence rate Yr. 2 | Incidence rate Yr. 3 |
---|---|---|---|
Structural Testing Alone (VTDR+) | 19% | 31% | 53% |
Functional Test Alone: RETeval DR Score > 23.4 | 23% | 41% | 65% |
Functional & Structural: VTDR+ and RETeval DR Score > 23.4 | 34% | 54% | 74% |
Functional & Structural: VTDR+ and RETeval DR Score ≤ 23.4 | 3% | 4% | 29% |
Testing method | Incidence rate Yr. 1 | Incidence rate Yr. 2 | Incidence rate Yr. 3 |
---|---|---|---|
Structure: (ETDRS-DR) severity ≥ level 53 | 19% | 31% | 53% |
Function: ≥23.4 DR score RETeval | 34% | 54% | 74% |
Risk reduction with score below 23.4 | 3% | 4% | 29% |
Conclusion: Know whom and when to provide an intervention. The RETeval device provides a superior progression risk assessment. Combining structural and functional information provides even better results.
SIMPLE TO USE & Interpret
- Handheld, light, and portable
- Appropriate for any age without sedation
- Train technicians in minutes
- Mac and Windows Compatible
No Corneal Contact
- Our non-invasive LKC patented Sensor Strip skin electrodes mean no corneal electrode required
Test Without Dilation
- Real-time pupillography adjusts for pupil size in real time
- DR Assesment is conducted prior to dilation
ERG: Functional stress generally precedes structural damage
Disease Onset
Functional Stress
ERG Technology
Structural Damage
Structural Imaging
Vision Loss
Modern Fundamentals of Diabetic Retinopathy Management in Optometry
A team of 14 optometrists set out to simplify and standardize diabetic retinopathy (DR) assessment and management by developing a set of practical guidelines for their peers. Their collaboration presents a framework to improve the diagnosis and management of DR to support improved patient outcomes and allow primary eye care providers to confidently care for the growing population of patients with diabetes.
DR Videos
Reports
Color-coded results compared to an age-adjusted reference data set make intreptation straightforward and efficient in a busy practice. Results are easily exported into any EMR/EHR system.
Age-adjusted reference data for ease of interpretation
Final DR Assessment Score
Bi-polar functional stress compared to reference
Pupil response compared to reference
How It Works
RETeval device will start flashing light into the patient's eye.
The retina responds to the flashes by generating small electrical signals that travel through the facial structure to the sensor strip.
The Sensor Strip detects the electrical signals and compares the results to the age-adjusted reference database.
Product Experience
Let’s Talk!
Book a demo or jump on a phone call with a sales rep in your area